Langerhans cell histiocytosis in a patient with stage 4 neuroblastoma receiving oral fenretinide

Melissa Rayburg, Alexander Towbin, Hong Yin, Todd Maugans, Barry Maurer, Rajaram Nagarajan, Brian Weiss

Research output: Contribution to journalArticle

Abstract

Langerhans cell histiocytosis (LCH) has previously been reported in association with other malignancies. The pathogenesis of LCH and its relationship to other malignancies is poorly understood. We present a novel case of a child who developed an LCH bone lesion while receiving a Phase I protocol therapy with oral fenretinide/Lym-X-Sorb (4-HPR/LXS) powder for neuroblastoma.

Original languageEnglish (US)
Pages (from-to)1111-1113
Number of pages3
JournalPediatric Blood and Cancer
Volume53
Issue number6
DOIs
StatePublished - Dec 8 2009
Externally publishedYes

Fingerprint

Fenretinide
Langerhans Cell Histiocytosis
Neuroblastoma
Powders
Neoplasms
Bone and Bones
Therapeutics

Keywords

  • Fenretinide
  • LCH
  • Neuroblastoma
  • New agents
  • Pediatric oncology

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Rayburg, M., Towbin, A., Yin, H., Maugans, T., Maurer, B., Nagarajan, R., & Weiss, B. (2009). Langerhans cell histiocytosis in a patient with stage 4 neuroblastoma receiving oral fenretinide. Pediatric Blood and Cancer, 53(6), 1111-1113. https://doi.org/10.1002/pbc.22200

Langerhans cell histiocytosis in a patient with stage 4 neuroblastoma receiving oral fenretinide. / Rayburg, Melissa; Towbin, Alexander; Yin, Hong; Maugans, Todd; Maurer, Barry; Nagarajan, Rajaram; Weiss, Brian.

In: Pediatric Blood and Cancer, Vol. 53, No. 6, 08.12.2009, p. 1111-1113.

Research output: Contribution to journalArticle

Rayburg, M, Towbin, A, Yin, H, Maugans, T, Maurer, B, Nagarajan, R & Weiss, B 2009, 'Langerhans cell histiocytosis in a patient with stage 4 neuroblastoma receiving oral fenretinide', Pediatric Blood and Cancer, vol. 53, no. 6, pp. 1111-1113. https://doi.org/10.1002/pbc.22200
Rayburg, Melissa ; Towbin, Alexander ; Yin, Hong ; Maugans, Todd ; Maurer, Barry ; Nagarajan, Rajaram ; Weiss, Brian. / Langerhans cell histiocytosis in a patient with stage 4 neuroblastoma receiving oral fenretinide. In: Pediatric Blood and Cancer. 2009 ; Vol. 53, No. 6. pp. 1111-1113.
@article{0ba6e33ac9764706ba07df8b7911faee,
title = "Langerhans cell histiocytosis in a patient with stage 4 neuroblastoma receiving oral fenretinide",
abstract = "Langerhans cell histiocytosis (LCH) has previously been reported in association with other malignancies. The pathogenesis of LCH and its relationship to other malignancies is poorly understood. We present a novel case of a child who developed an LCH bone lesion while receiving a Phase I protocol therapy with oral fenretinide/Lym-X-Sorb (4-HPR/LXS) powder for neuroblastoma.",
keywords = "Fenretinide, LCH, Neuroblastoma, New agents, Pediatric oncology",
author = "Melissa Rayburg and Alexander Towbin and Hong Yin and Todd Maugans and Barry Maurer and Rajaram Nagarajan and Brian Weiss",
year = "2009",
month = "12",
day = "8",
doi = "10.1002/pbc.22200",
language = "English (US)",
volume = "53",
pages = "1111--1113",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Langerhans cell histiocytosis in a patient with stage 4 neuroblastoma receiving oral fenretinide

AU - Rayburg, Melissa

AU - Towbin, Alexander

AU - Yin, Hong

AU - Maugans, Todd

AU - Maurer, Barry

AU - Nagarajan, Rajaram

AU - Weiss, Brian

PY - 2009/12/8

Y1 - 2009/12/8

N2 - Langerhans cell histiocytosis (LCH) has previously been reported in association with other malignancies. The pathogenesis of LCH and its relationship to other malignancies is poorly understood. We present a novel case of a child who developed an LCH bone lesion while receiving a Phase I protocol therapy with oral fenretinide/Lym-X-Sorb (4-HPR/LXS) powder for neuroblastoma.

AB - Langerhans cell histiocytosis (LCH) has previously been reported in association with other malignancies. The pathogenesis of LCH and its relationship to other malignancies is poorly understood. We present a novel case of a child who developed an LCH bone lesion while receiving a Phase I protocol therapy with oral fenretinide/Lym-X-Sorb (4-HPR/LXS) powder for neuroblastoma.

KW - Fenretinide

KW - LCH

KW - Neuroblastoma

KW - New agents

KW - Pediatric oncology

UR - http://www.scopus.com/inward/record.url?scp=71049124468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71049124468&partnerID=8YFLogxK

U2 - 10.1002/pbc.22200

DO - 10.1002/pbc.22200

M3 - Article

C2 - 19621427

AN - SCOPUS:71049124468

VL - 53

SP - 1111

EP - 1113

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 6

ER -